首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1448385

凝血分析儀的全球市場規模、佔有率和成長分析：按產品和最終用戶 - 產業預測（2024-2031）

Global Coagulation Analyzer Market Size, Share, Growth Analysis, By Product(Standalone and Integrated systems), By End-user(Hospitals, Diagnostic centers) - Industry Forecast 2024-2031

出版日期: 2024年03月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球凝血分析儀市場規模將為44.3億美元，預測期內（2024-2031年）複合年成長率為6.0%，從2023年的47億美元成長到2031年的74.8億美元。

心血管疾病和凝血障礙的盛行率不斷上升，推動了全球凝血分析儀市場的顯著成長。抗凝血治療的監測和管理在很大程度上依賴這些分析設備。技術開拓可以實現更快、更準確的觀察，再加上不斷上漲的醫療成本，正在推動市場發展。易於使用的攜帶式設備越來越受歡迎。主要相關人員專注於改善患者治療效果的創造性方法。

然而，嚴格的法規和定價要求帶來了挑戰。市場佔有率主要由北美和歐洲佔據，亞太地區顯示出成長潛力。由於對有效凝血監測的需求不斷增加，預計該市場將繼續成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Roche Diagnostics-Switzerland
Siemens Healthineers-Germany
Abbott Laboratories-United States
Sysmex Corporation-Japan
Thermo Fisher Scientific-United States
Instrumentation Laboratory（IL）-United States
Helena Laboratories-United States
Nihon Kohden-Japan
Diagnostica Stago-France
Werfen-Spain
Grifols-Spain
International Technidyne Corporation（ITC）-United States
CoaguSense-United States
HemoSonics-United States
Helena Biosciences-United Kingdom
Randox Laboratories-United Kingdom
Helena Point of Care-United States
Medtronic-Ireland
EKF Diagnostics-United Kingdom
Hycor Biomedical-United States

簡介目錄

Product Code: SQMIG35A2462

Global Coagulation Analyzer Market size was valued at USD 4.43 billion in 2022 and is poised to grow from USD 4.70 billion in 2023 to USD 7.48 billion by 2031, at a CAGR of 6.0% during the forecast period (2024-2031).

The growing prevalence of cardiovascular illnesses and clotting disorders is driving substantial growth in the global market for coagulation analyzers. Anticoagulant therapy monitoring and management depend heavily on these analyzers. Technological developments that allow for quicker and more precise findings, combined with rising healthcare costs, are driving the market. Devices that are easy to use and portable are becoming more popular. Important actors are concentrating on creative ways to improve patient outcomes.

Strict rules and pricing demands, however, provide difficulties. The market share is dominated by North America and Europe, with Asia-Pacific showing potential for growth. All things considered, the market is expected to keep growing because of the increasing demand for effective coagulation monitoring.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Coagulation Analyzer Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coagulation Analyzer Market Segmental Analysis

The product type, end-user, and geographic segments of the worldwide coagulation analyzer market may be distinguished. Integrated and stand-alone systems are among the product kinds. Research institutes, hospitals, and diagnostic centers are examples of end-users. North America, Europe, Asia-Pacific, and the rest of the globe make up the market's geographical boundaries.

Drivers of the Global Coagulation Analyzer Market

Aging populations around the world are linked to a higher risk of a number of illnesses, including coagulation disorders. The need for coagulation analyzers to diagnose and track clotting disorders including hemophilia and deep vein thrombosis (DVT) is expected to rise with the aging population.

Restraints in the Global Coagulation Analyzer Market

The cost of buying and maintaining coagulation analyzers can be high, particularly for smaller healthcare facilities and areas with limited resources. For healthcare providers, the initial expenditure, as well as expenses for reagents, maintenance, and routine calibration, can be very costly.

Market Trends of the Global Coagulation Analyzer Market

Automation and Technological improvements: The market for coagulation analyzers has been seeing a trend toward greater automation and technological improvements. The goal of manufacturers was to create analyzers with better efficiency, accuracy, and user interfaces. Automation elements that were becoming increasingly widespread included sample loading automation, barcode scanning, and interaction with laboratory information systems. These developments were made with the intention of improving overall laboratory productivity, streamlining testing procedures, and lowering human error.

Growing requirement for Point-of-Care Testing: The requirement for quick results and decentralized testing led to an increase in the demand for point-of-care coagulation testing. Healthcare professionals now have access to real-time information regarding a patient's coagulation status in a variety of clinical settings, including operating rooms, critical care units, and emergency departments, thanks to point-of-care coagulation analyzers. Patients on anticoagulant therapy or those with bleeding issues should pay special attention to this development.

Growing Emphasis on Patient-Centric Care and Personalized Medicine: The market for coagulation analyzers was being impacted by the shift in healthcare trends toward patient-centric care and personalized medicine. More emphasis was being placed by laboratories and healthcare practitioners on individualized treatment programs that took into account the unique characteristics of each patient, including coagulation profiles. To support these individualized treatment approaches, coagulation analyzers that could give precise and thorough data on a patient's coagulation status were in high demand.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Coagulation Analyzer Market by Product

Market Overview
Standalone and Integrated systems

Global Coagulation Analyzer Market by End-user

Market Overview
Hospitals
Diagnostic centers
and Research institutes

Global Coagulation Analyzer Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Roche Diagnostics - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Instrumentation Laboratory (IL) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostica Stago - France
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werfen - Spain
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols - Spain
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
International Technidyne Corporation (ITC) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoaguSense - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HemoSonics - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Biosciences - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Point of Care - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EKF Diagnostics - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hycor Biomedical - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments